Nitrofurantoin update

Nitrofurantoin is now contraindicated in patients with an eGFR of less than 45ml/min. This is a change to previous guidance issued by the MHRA following a review of the evidence.

Recent changes in controlled drug legislation for tramadol, lisdexamfetamine, zopiclone and zalepon

The following changes will take effect on the 10th June 2014: Tramadol Tramadol will become a schedule 3 Controlled Drug […]